Private Equity
The firm’s co-chief executives and board of directors have pledged 100% of their base salaries over the next six months to support portfolio companies.
2 min read · 02 April 2020
Joncarlo Mark, a former senior portfolio manager at CalPERS, gives his take on the current market: how LP co-investments will fare, what the opportunity set looks like and whether LPs will have to ‘walk away’ from some capital commitments.
8 min read · 02 April 2020
Co-investment opportunities have dried up along with the broader deal environment, but many LPs continue to seek ways to invest alongside GPs into deals.
5 min read · 02 April 2020
Foreign PE firms looking to acquire healthcare-related companies in Europe can expect another three months of FDI review added to the deal process.
3 min read · 02 April 2020
An exclusive investor survey conducted by PEI reveals three quarters of LPs will not reduce their target allocations to private markets in the face of the denominator effect.
3 min read · 01 April 2020
LPs will consider the amount of capital raised and deployed, and whether any investments are already underwater when granting GPs more time to raise funds during the coronavirus crisis.
4 min read · 31 March 2020
Gabriel de Alba, Catalyst’s managing director and partner, sees the disruptive impact of the covid-19 outbreak as potentially lasting throughout 2020 and into 2021.
3 min read · 31 March 2020
All foreign transactions will be subject to FIRB review, a process that will now take six months instead of 30 days.
2 min read · 31 March 2020
A number of GPs are using flush balance sheets to seed their own distressed debt funds, according to firm head Michael Rees.
2 min read · 30 March 2020
The firm held the final close on Carlyle Japan Partners IV last week on around $2.4bn, more than double its 2013-vintage predecessor.
3 min read · 30 March 2020
